Merus N.V. logo
Merus N.V. MRUS

Quartalsbericht 2025-Q3
hinzugefügt 31.10.2025

report update icon

Merus N.V. Langfristiger Schuldenstrom 2011-2026 | MRUS

Langfristiger Schuldenstrom Jährlich Merus N.V.

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
1.7 M 1.67 M 1.68 M 1.49 M 1.43 M 1.38 M - - - - - - - -

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
1.7 M 1.38 M 1.56 M

Langfristiger Schuldenstrom anderer Aktien in der Pharmaeinzelhändler

Name Langfristiger Schuldenstrom Preis % 24h Marktkapitalisierung Land
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
1.27 M - - $ 26.5 M usaUSA
MorphoSys AG MorphoSys AG
MOR
3.63 M - 2.43 % $ 254 M germanyGermany
Allakos Allakos
ALLK
3.25 M - - $ 28.6 M usaUSA
Advaxis Advaxis
ADXS
166 K - -9.65 % $ 45.9 M usaUSA
Alterity Therapeutics Limited Alterity Therapeutics Limited
ATHE
57.6 K $ 4.57 -0.22 % $ 11 B australiaAustralia
Akouos Akouos
AKUS
671 K - 0.23 % $ 488 M usaUSA
AlloVir AlloVir
ALVR
316 K - 4.14 % $ 49.1 M usaUSA
Compugen Ltd. Compugen Ltd.
CGEN
768 K $ 2.65 -2.93 % $ 248 M israelIsrael
I-Mab I-Mab
IMAB
8.06 M - - $ 866 M chinaChina
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
625 K - - $ 1.01 B usaUSA
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
274 K - -11.43 % $ 502 K usaUSA
Aptorum Group Limited Aptorum Group Limited
APM
433 K $ 0.88 - $ 6.47 M chinaChina
ACADIA Pharmaceuticals ACADIA Pharmaceuticals
ACAD
9.96 M $ 22.5 -0.75 % $ 3.73 B usaUSA
Applied Molecular Transport Applied Molecular Transport
AMTI
4.64 M - - $ 10.1 M usaUSA
AIkido Pharma AIkido Pharma
AIKI
554 K - 1.93 % $ 17.4 M usaUSA
Applied Therapeutics Applied Therapeutics
APLT
429 K - - $ 8.42 M usaUSA
Aptinyx Aptinyx
APTX
337 K - -39.0 % $ 4.57 M usaUSA
Galapagos NV Galapagos NV
GLPG
1.73 M $ 27.55 -3.08 % $ 2.69 B belgiumBelgium
Genmab A/S Genmab A/S
GMAB
26 M $ 25.89 -3.36 % $ 16 B danmarkDanmark
Aeterna Zentaris Aeterna Zentaris
AEZS
215 K - 5.93 % $ 314 M canadaCanada
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
419 K - - $ 7.46 M israelIsrael
AgeX Therapeutics AgeX Therapeutics
AGE
181 K - -10.17 % $ 12.2 K usaUSA
Aravive Aravive
ARAV
2.2 M - -13.39 % $ 1.45 M usaUSA
Aridis Pharmaceuticals Aridis Pharmaceuticals
ARDS
538 K - 17.91 % $ 11.1 M usaUSA
Atreca Atreca
BCEL
3.54 M - -11.76 % $ 5.79 M usaUSA
BioNTech SE BioNTech SE
BNTX
45 M $ 100.4 -1.63 % $ 27.2 B germanyGermany
Brainstorm Cell Therapeutics Brainstorm Cell Therapeutics
BCLI
208 K - -2.5 % $ 5.88 M usaUSA
Innoviva Innoviva
INVA
418 K $ 23.23 -1.94 % $ 1.57 B usaUSA
Aquestive Therapeutics Aquestive Therapeutics
AQST
631 K $ 4.07 -0.61 % $ 435 M usaUSA
Jaguar Health Jaguar Health
JAGX
192 K $ 0.23 -5.27 % $ 536 K usaUSA
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
294 K $ 22.56 -3.13 % $ 2.87 B usaUSA
KalVista Pharmaceuticals KalVista Pharmaceuticals
KALV
1.62 M $ 26.71 38.8 % $ 1.44 B britainBritain
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
4.56 M $ 1.4 -5.74 % $ 373 M britainBritain
Kamada Ltd. Kamada Ltd.
KMDA
2.12 M $ 8.15 - $ 260 M israelIsrael
Aptose Biosciences Aptose Biosciences
APTO
193 K - -45.71 % $ 1.2 M canadaCanada
AstraZeneca PLC AstraZeneca PLC
AZN
382 M - - $ 96.9 B britainBritain
AVROBIO AVROBIO
AVRO
878 K - 1083.1 % $ 745 M usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
43 K $ 2.88 -1.03 % $ 4.74 M israelIsrael
BeiGene, Ltd. BeiGene, Ltd.
BGNE
20.7 M - 0.49 % $ 251 B cayman-islandsCayman-islands